Products for Research Use Only
RegisterLogin

SARS-CoV-2-IN-59

CAT: 0804-HY-W348072Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W348072Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SARS-CoV-2-IN-59 (compound E07), an imidazoline derivative, is a non-peptide small molecule inhibitor of SARS-CoV-2 that targets the main protease (Mpro) of the coronavirus. SARS-CoV-2-IN-59 has a strong interaction with residues on Mpro (Met 165, Gln 166, Met 165, His 41, Gln 189) [1].
CAS Number
850786-33-3
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-59.html
Solubility
10 mM in DMSO
Smiles
N#CC1=CC=C(C2=NCCN2)C=C1
Molecular Formula
C10H9N3
Molecular Weight
171.20
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Azimi S, et al. Green and rapid and instrumental one-pot method for the synthesis of imidazolines having potential anti-SARS-CoV-2 main protease activity. Sustain Chem Pharm. 2023 Sep;34:101136.. .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-135856-01SARS-CoV-IN-2
HY-156337SARS-CoV-2-IN-63
HY-143417SARS-CoV-2-IN-16
HY-162777SARS-CoV-2-IN-93
HY-162414SARS-CoV-2-IN-84
HY-148387SARS-CoV-2-IN-35
HY-168107SARS-CoV-2-IN-98
HY-162604SARS-CoV-2-IN-90
HY-155308SARS-CoV-2-IN-61
HY-169419SARS-CoV-2-IN-108

Alternative Products

CatalogName
T80636-01SARS-CoV-2-IN-59
GTR18678023-01SARS-CoV/SARS-CoV-2 Spike Antibody
BA1949-5SARS-CoV-IN-2
553226SARS-CoV-2
Oneq-S827-150RSARS CoV-2
C21524-50uLSARS-CoV/SARS-CoV-2 Nucleocapsid Antibody [E8H21]
GTR18595045-01SARS CoV/SARS CoV 2 Spike Human mAb

Popular Products